Skip to main content

Table 2 Correlation analyses of CSF sTREM2 in relation to age in the Norwegian and the Swedish cohorts

From: Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

  Correlations between sTREM2 and age
  Norwegian cohort Swedish cohort Norwegian and Swedish cohort
  All (n = 100) AD (n = 29) MCI (n = 21) Control (n = 50) Aβ42 > 700 (n = 46) All (n = 50) AD (n = 25) Control (n = 25) All (n = 150) AD (n = 54) Control (n = 75)
Age r = 0.34 r = 0.08 r = 0.03 r = 0.53 r = 0.56 r = 0.35 r = 0.46 r = 0.35 r = 0.29 r = 0.00 r = 0.50
p < 0.001 p = 0.69 p = 0.86 p < 0.001 p < 0.001 p = 0.01 p = 0.02 p = 0.08 p < 0.001 p = 1.00 p < 0.001
  1. Correlation analyses of CSF sTREM2 in relation to age of AD, MCI and control patients of the two cohorts
  2. Correlations are presented as Spearman rho (r) since most data not were normally distributed
  3. Aβ42 amyloid beta 1–42, AD Alzheimer’s disease, CSF cerebrospinal fluid, MCI mild cognitive impairment, sTREM2 soluble triggering receptor expressed on myeloid cells 2